Millennium Management’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Millennium Management’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-27,043	Closed	-$44K	–	7948
2021 Q4	$44K	Sell	27,043 -74,611	-73%	-$226K	﹤0.01%	6510
2021 Q3	$422K	Buy	+101,654	New	+$523K	﹤0.01%	5503
2021 Q2	–	Sell	-92,104	Closed	-$778K	–	7343
2021 Q1	$778K	Buy	+92,104	New	+$963K	﹤0.01%	4443

Other funds holding SCPS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management's SCPS Position: Q1 2022 in Review

Millennium Management sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q1 2022, closing a stake of 27,043 shares — an estimated $44K sold.

Millennium Management first reported a position in SCPS in Q1 2021 and held it in 3 quarters. The position peaked at $778K in Q1 2021. 19 funds tracked by Wall St. Rank hold SCPS as of Q1 2022.

Millennium Management reported no remaining Scopus BioPharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Millennium Management sold 27,043 Scopus BioPharma Inc. Common Stock shares in Q1 2022, an estimated $44K.
Millennium Management first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Millennium Management's Scopus BioPharma Inc. Common Stock position peaked at $778K in Q1 2021.
19 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.